Univeristy of Chicago Medical Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Catenacci, Daniel
NCT02366819: Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Recruiting
4
36
US
Oxaliplatin, Leucovorin Calcium, CF, Irinotecan Hydrochloride, Fluorouracil, Conventional Surgery, surgery, conventional
University of Chicago, National Cancer Institute (NCI)
Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Stage IIB Gastric Cancer, Stage IIIA Esophageal Adenocarcinoma, Stage IIIA Gastric Cancer, Stage IIIB Esophageal Adenocarcinoma, Stage IIIB Gastric Cancer, Stage IIIC Esophageal Adenocarcinoma, Stage IIIC Gastric Cancer
06/25
06/25
NCT04089904: Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma

Terminated
2
3
US
Pembrolizumab Injection
University of Chicago
Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma
03/23
03/23
NCT04231526: Pembrolizumab in Early Stage Colon Cancer

Withdrawn
2
46
US
Pembrolizumab, Surgery
University of Chicago, Merck Sharp & Dohme LLC
Colon Cancer
12/22
12/22
I-FLOAT, NCT04361708: Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Recruiting
1
54
US
Oxaliplatin, Docetaxel, Leucovorin, Irinotecan, 5-Fluorouracil
University of Chicago
Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma
06/25
05/27
COLOMATE, NCT03765736: Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a Trial

Terminated
N/A
199
US
Genetic Testing, genetic analysis, Genetic Examination, Genetic Test
Academic and Community Cancer Research United, National Cancer Institute (NCI)
Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Colon Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Colon Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Colon Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8, Stage IV Colon Cancer AJCC v8, Stage IV Rectal Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8, Stage IVA Rectal Cancer AJCC v8, Stage IVB Colon Cancer AJCC v8, Stage IVB Rectal Cancer AJCC v8, Stage IVC Colon Cancer AJCC v8, Stage IVC Rectal Cancer AJCC v8, Unresectable Colon Adenocarcinoma, Unresectable Rectal Adenocarcinoma
12/23
12/23
NCT01416714: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

Recruiting
N/A
1000
US
University of Chicago
Gastric Cancers
01/30
01/30

Download Options